To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Astelin Nasal Spray Seasonal Allergic Rhinitis Drug Approved by FDA URL: http://www.pslgroup.com/dg/D736.htm Doctor's Guide November 4, 1996
CRANBURY, N.J.-- Nov. 4, 1996 -- The Food and Drug Administration today announced approval of Astelin(R) (azelastine HCL) nasal spray, from Wallace Laboratories, for a complex of systems associated with seasonal allergic rhinitis. Astelin(R) enters the $1.5 billion prescription seasonal allergic rhinitis market and is the first prescription antihistamine spray for seasonal allergic rhinitis in the United States. It offers a valuable treatment option for the estimated 20-40 million Americans who suffer from seasonal allergic rhinitis, the fifth most common chronic illness that causes millions of lost work days and significant discomfort for the sufferer. Wallace Laboratories is a division of Carter-Wallace, Inc. (NYSE:CAR). --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.